Average weight loss with Contrave is approximately 5-8% of body weight, lower than tirzepatide but meaningful for people whose weight gain is driven by emotional eating, food addiction, or reward-seeking behavior patterns
This is a clean draw on both 50 unit and 100 unit syringes, falling between the 42 and 46 graduation lines on a 100 unit syringe or directly on the 44 line on a 50 unit syringe
Lifestyle factors such as nutrition, exercise, and metabolic health also play a role
Users in studies lost up to 20 percent of their body weight, which is far more than the outcomes realized in other treatments
Potential Benefits (What We Can Hope For) Slowing or delaying onset of dementia , especially in people with risk factors: T2DM, obesity, metabolic syndrome, hypertension